Yan Wang

机构：Shengli Oilfield Central Hospital · ORCID：0000-0002-6122-9437

发表论文 208 篇 · 总被引 8043 次 · h-index 43

代表论文

• Cytokine polarized, alternatively activated bone marrow neutrophils drive axon regeneration (2024 · Nature Immunology · 被引 33)
• IL-6 predicts CDK4/6 inhibitor resistance, identifying STAT3 as a target in HR + /HER2-negative metastatic breast cancer (2025 · npj Precision Oncology · 被引 14)
• A protocol for a multidisciplinary early intervention during chemotherapy to improve dietary management behavior in breast cancer patients: a two-arm, single-center randomized controlled trial (2024 · BMC Cancer · 被引 11)
• Combination therapy and dual-target inhibitors based on cyclin-dependent kinases (CDKs): Emerging strategies for cancer therapy (2025 · European Journal of Medicinal Chemistry · 被引 10)
• Abstract 4622: Anti-tumor activity of CDK2 inhibitor BLU-222 in combination with CDK4/6 inhibitors for overcoming resistance in HR positive and triple negative metastatic breast cancers models (2024 · Cancer Research · 被引 5)
• miR-449a disturbs atherosclerotic plaque stability in streptozotocin and high-fat diet-induced diabetic mice by targeting CEACAM1 (2024 · Diabetology & Metabolic Syndrome · 被引 4)